<DOC>
	<DOCNO>NCT02119013</DOCNO>
	<brief_summary>Autosomal dominant polycystic kidney disease ( ADPKD ) associate early onset hypertension leave ventricular ( LV ) hypertrophy . Since LV hypertrophy associate LV diastolic function impairment , aim ass change time LV diastolic function ADPKD patient whether affected treatment somatostatin analogue , octreotide . 35 ADPKD patient ( 14 male ) age 34±8 year ( mean glomerular filtration rate 82±26 mL/min/1.73m2 ) randomly assign 36 month treatment placebo ( n=18 ) octreotide ( n=17 ) . Clinical echocardiography parameter evaluate baseline study end . LV mass ( M ) ejection fraction ( EF ) calculate accord Devereux formula biplane Simpson 's algorithm , respectively . LV fill assessed mitral pulmonary vein flow velocity curve mitral annulus early diastolic velocity peak ( Ea ) tissue Doppler imaging .</brief_summary>
	<brief_title>Effects Somatostatin ADPKD Heart</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney Diseases</mesh_term>
	<mesh_term>Polycystic Kidney , Autosomal Dominant</mesh_term>
	<criteria>diagnosis autosomal dominant polycystic kidney disease glomerular filtration rate grater 40 ml/min diabetes mellitus proteinuria great 1 g/24 hour significant glomerular disease urinary tract lithiasis infection symptomatic gallstone biliary sludge cancer pregnant woman lactanting woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>